Priority Date: 20.05.10 (US 20100346617P)

THERAPEUTIC USE OF THE ss2-MICROGLOBULIN PROTEIN

  • Application ID: EP11717774
  • Status: PATENT GRANTED

Attorney

operating since 1977
1167.6
Headquarter in Paris and 4 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and G01 (MEASURING; TESTING). We found, that Coller IP Management Ltd, TransMIT GmbH, Kailuweit & Uhlemann, Bock Bieber Donath, Engel Patentanwaltskanzlei and 172 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 20.05.2010 - Priority Date (US 20100346617P)
  • 13.10.2011 - Publication A1 (WO2011125029)
  • 13.02.2013 - Publication A1 (EP2555790)
  • 08.06.2016 - Publication B1 (EP2555790)